Condition: Gastric Cancer · Gastric Intestinal Metaplasia · Gastric Atrophy · Sponsor: University of Latvia
The project will aim to identify and determine subgroups of patients with different risks of progression to gastric cancer and to assess appropriate follow-up intervals. Implementing risk stratification only high risk individuals will be offered and performed endoscopic surveillance.
This description comes directly from the study's public registry record.
Ilze Kikuste, PhD · 28357349 · ikikuste@gmail.com
Always discuss trial participation with your own doctor first.
| University of Latvia | Riga, Latvia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03250091